BB&T

Summary

BB&T is the famous Corporate Investor, which was founded in 1872. The leading representative office of defined Corporate Investor is situated in the Winston Salem. The fund was located in North America if to be more exact in United States.

Among the most popular portfolio startups of the fund, we may highlight Kythera Biopharmaceuticals, CVRx, OvaScience. We can highlight the next thriving fund investment areas, such as Life Science, Biotechnology. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Besides them, we counted 25 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the BB&T, startups are often financed by Versant Ventures, The New York Times, Prospect Venture Partners. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Prospect Venture Partners, New Enterprise Associates. In the next rounds fund is usually obtained by Ysios Capital, Versant Ventures, Sterling Capital Management.

The important activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this BB&T works on 21 percentage points more the average amount of lead investments. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top amount of exits for fund were in 2013.